Company Active LTD

Company profile

Nunabio Limited

Home - NunaBio

Synthetic DNA production for cutting-edge biotechnology solutions.

CRN
08093593
Founded
2012
Age
14

Overview

Legal name
NUNABIO LIMITED
Region
North East England
Registered address
TIME CENTRAL
32 GALLOWGATE
NEWCASTLE UPON TYNE
TYNE AND WEAR
UNITED KINGDOM
NE1 4BF
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
17

Company events

Reference milestones and recent Companies House filing stream events.

14 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

20 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

19 Jun
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUyNzM0MDMxNGFkaXF6a2N4

Published 19 Jun 2026 14:16

23 May
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUYxSzFHMTVhZGlxemtjeA | Paper/PDF filed

Published 23 May 2026 22:43

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

06 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

21 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MDMyMjQ0OWFkaXF6a2N4

Published 21 Oct 2024 03:22

21 Oct
2024

Appoint Corporate Director Company With Name Date

Officers

AP02 | Transaction MzQ0MDMyMjQ1MWFkaXF6a2N4

Published 21 Oct 2024 03:22

03 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzODMyMzgzMWFkaXF6a2N4

Published 03 Oct 2024 03:52

27 Sep
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzNzUxODIyOWFkaXF6a2N4

Published 27 Sep 2024 12:06

09 Sep
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURCMTlLMEJhZGlxemtjeA | Paper/PDF filed

Published 10 Sep 2024 06:22

09 Sep
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURCMTlLU0JhZGlxemtjeA | Paper/PDF filed

Published 10 Sep 2024 06:15

28 Aug
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzMzY0NTQyMGFkaXF6a2N4

Published 28 Aug 2024 13:36

06 Jun
2012

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2021
Funded years
2021, 2023
Age at first award
8 years

Projects

2023 Collaborative R&D Lead participant

Scalable economic DNA synthesis by oligoseed amplification with novel DNA polymerase enzymes

1 Sep 2023 to 28 Feb 2025

Awarded
£257,168
Total cost £367,383

Engineered DNA is an enabler for the UK's economic success (UK-Innovation-Strategy-2021). It is a mainstream component for cell and gene therapies, advanced diagnostics, and RNA vaccines. Hundreds of kilograms of DNA will soon be required globally each year, much more than current global capacity to supply it. The long-standing mainstream DNA production m...

2023 Collaborative R&D Lead participant

Automated surface-bound oligoseed DNA amplification enabling advanced therapies and diagnostics

1 Apr 2023 to 31 Mar 2025

Awarded
£363,795
Total cost £519,707

Synthetic DNA is a mainstream component for wide-ranging established and emerging industries including cell and gene therapies and molecular diagnostics. The global DNA synthesis market is forecast to reach £3.4bn by 2025, with demand reaching hundreds of kilograms in coming years and vastly outstripping supply. Solid phase phosphoramidite chemistry, the ...

2021 Study Lead participant

Nunabio: Providing DNA Solutions

1 Apr 2021 to 30 Sep 2022

Awarded
£209,486
Total cost £299,265

Biological matter can be precisely identified by the base sequence of its DNA. DNA detection is therefore of global interest where biological contamination is harmful to human health -- water that contains microbial infections, air samples that convey disease, water or food that is contaminated, weapons that disperse biological agents or genetic mutations...

Product types

Collaborative R&D Study